| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 15,095 | $1.45 M | $96.38 | May 23, 2023 | Direct |
| Syros Pharmaceuticals, Inc. | Director | Common Stock | 3,666 | $16.2 K | $4.42 | Sep 16, 2023 | Direct |
| Syros Pharmaceuticals, Inc. | Director | Restricted Stock Units | 5,334 | $11.8 K | $2.22 | Sep 16, 2023 | Direct |
| Turning Point Therapeutics, Inc. | Director | Common Stock | 0 | $76.00 | Aug 17, 2022 | Direct | |
| Turning Point Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Aug 17, 2022 | Direct |